Evelo Biosciences upgraded by Jefferies with a new price target
$EVLO
Biotechnology: Pharmaceutical Preparations
Health Care
Jefferies upgraded Evelo Biosciences from Hold to Buy and set a new price target of $18.00 from $11.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/2/2021 | $44.00 → $41.50 | Market Outperform | JMP Securities |
| 11/1/2021 | $12.00 | Neutral → Buy | Chardan Capital Markets |
| 6/23/2021 | $36.00 → $38.00 | Market Outperform | JMP Securities |
| 6/23/2021 | $28.00 | Overweight | Cantor Fitzgerald |
EFFECT - Evelo Biosciences, Inc. (0001694665) (Filer)
15-12G - Evelo Biosciences, Inc. (0001694665) (Filer)
S-8 POS - Evelo Biosciences, Inc. (0001694665) (Filer)
4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
4 - Evelo Biosciences, Inc. (0001694665) (Issuer)
4 - Evelo Biosciences, Inc. (0001694665) (Issuer)